aluminum phosphate has been researched along with lipid a in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (20.00) | 18.2507 |
2000's | 3 (60.00) | 29.6817 |
2010's | 1 (20.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chroscinski, EA; Cross, PJ; Griffith, JW; Lang, CM; Light, TE; Robuccio, JA | 1 |
Allen, C; Ambrosino, DM; Bernstein, H; Duncan, DD; Dunn, J; Eldridge, J; LaPosta, V; Laussucq, S; MacDonald, K; Molrine, DC; Pelton, S; Tsao, G; Vernacchio, L | 1 |
Clements, JD; Katz, J; Marciani, DJ; Martin, M; Michalek, SM; Yang, QB; Zhang, P | 1 |
Kundi, M | 1 |
Bottazzi, ME; Curti, E; Du, L; Hotez, PJ; Jiang, S; Jones, K; Lustigman, S; Tseng, CT; Zhan, B | 1 |
1 review(s) available for aluminum phosphate and lipid a
Article | Year |
---|---|
New hepatitis B vaccine formulated with an improved adjuvant system.
Topics: Adjuvants, Immunologic; Adolescent; Adult; Aluminum Compounds; Chemistry, Pharmaceutical; Hepatitis B; Hepatitis B Vaccines; Humans; Immunization Programs; Immunization Schedule; Kidney Failure, Chronic; Lipid A; Phosphates; Risk Factors; Vaccines, Synthetic | 2007 |
1 trial(s) available for aluminum phosphate and lipid a
Article | Year |
---|---|
Effect of monophosphoryl lipid A (MPL) on T-helper cells when administered as an adjuvant with pneumocococcal-CRM197 conjugate vaccine in healthy toddlers.
Topics: Adjuvants, Immunologic; Aluminum Compounds; Antibodies, Bacterial; Antigens, Bacterial; Bacterial Proteins; Child, Preschool; Cytokines; Female; Humans; Immunity, Cellular; Immunoglobulin G; Infant; Lipid A; Lymphocyte Activation; Male; Phosphates; Polysaccharides, Bacterial; T-Lymphocyte Subsets; T-Lymphocytes, Helper-Inducer; Vaccines, Conjugate; Vaccines, Synthetic | 2002 |
3 other study(ies) available for aluminum phosphate and lipid a
Article | Year |
---|---|
Comparison of the effects of five adjuvants on the antibody response to influenza virus antigen in guinea pigs.
Topics: Acetylmuramyl-Alanyl-Isoglutamine; Adjuvants, Immunologic; Aluminum Compounds; Animals; Antibodies, Viral; Antigens, Viral; Cell Wall Skeleton; Cord Factors; Freund's Adjuvant; Guinea Pigs; Hemagglutinin Glycoproteins, Influenza Virus; Hemagglutinins, Viral; Influenza B virus; Lipid A; Male; Phosphates; Poloxalene; Polysorbates; Squalene; Viral Envelope Proteins; Viral Vaccines | 1995 |
Effectiveness of the quillaja saponin semi-synthetic analog GPI-0100 in potentiating mucosal and systemic responses to recombinant HagB from Porphyromonas gingivalis.
Topics: Adhesins, Bacterial; Adjuvants, Immunologic; Administration, Intranasal; Aluminum Compounds; Animals; Antibodies, Bacterial; Antigens, Bacterial; Bacterial Proteins; Cholera Toxin; Female; Hemagglutinins; Immunity, Mucosal; Immunoglobulin A; Immunoglobulin G; Injections, Subcutaneous; Lectins; Lipid A; Mice; Mice, Inbred BALB C; Mucous Membrane; Phosphates; Porphyromonas gingivalis; Quillaja; Recombinant Proteins; Saliva; Saponins; Vagina | 2003 |
Roadmap to developing a recombinant coronavirus S protein receptor-binding domain vaccine for severe acute respiratory syndrome.
Topics: Adjuvants, Immunologic; Aluminum Compounds; Animals; Antibodies, Neutralizing; Antibodies, Viral; Antigens, Viral; Clinical Trials as Topic; Humans; Lipid A; Membrane Glycoproteins; Phosphates; Protein Structure, Tertiary; Severe Acute Respiratory Syndrome; Severe acute respiratory syndrome-related coronavirus; Spike Glycoprotein, Coronavirus; Vaccines, Subunit; Vaccines, Synthetic; Viral Envelope Proteins; Viral Vaccines | 2012 |